Boardroom Alpha
Meeting calendar
TLS · Annual meeting · Thursday, May 7, 2026

Telos Corp

7 nominees · 4 ballot items.

Election of seven directors; ratification of PwC as auditors; approval of Amendment No. 2 to the 2016 Omnibus Long-Term Incentive Plan to increase share reserve by 5,380,000; advisory approval of executive compensation (say-on-pay).

Market cap
$354M
1Y TSR
+60.4%
Board grade
D
Record date
Mar 10, 2026
Filing
DEF 14A
Meeting concluded · May 7, 2026

Follow how the vote landed and what changed on Telos Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.

Proposals

On the ballot4

  1. 1

    Election of Directors

    ManagementBoard: FOR

    Election of seven director nominees (John B. Wood, David Borland, Bonnie Carroll, Derrick D. Dockery, Brad Jacobs, John W. Maluda, Fredrick D. Schaufeld) to serve until the 2027 Annual Meeting.

  2. 2

    Ratification of Independent Registered Public Accounting Firm

    ManagementBoard: FOR

    Ratify the selection of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for fiscal year 2026.

  3. 3

    Approval of Amendment No. 2 to the Amended and Restated 2016 Omnibus Long-Term Incentive Plan

    ManagementBoard: FOR

    Approve Amendment No. 2 to increase shares available under the 2016 LTIP by 5,380,000 shares (subject to stockholder approval).

    More detail

    The Board seeks shareholder approval to amend the Company’s 2016 LTIP to increase the share reserve by 5,380,000 shares, citing the need to attract and retain talent and avoid increasing cash compensation. Management emphasizes that the additional shares are necessary for recruiting and retention, that many recent grants are performance-conditioned and may not vest fully, and that existing share repurchases and plan features mitigate dilution. The board argues that without the amendment it may need to increase cash compensation and take other strategic actions that could impair cash flow and hinder recruitment. The plan amendment would become effective if approved and would increase the aggregate authorized shares under the Plan, as reflected in a draft Exhibit A attached to the proxy. The Board’s recommendation is FOR, grounded in the strategic need to maintain competitive equity-based compensation and balance dilution concerns against hiring and retention risks.

  4. 4

    Advisory Vote on Executive Compensation (Say-on-Pay

    ManagementBoard: FOR

    Non-binding advisory vote to approve the compensation of the Company’s named executive officers as disclosed in the proxy (say-on-pay).

    More detail

    This proposal asks shareholders to cast a non-binding advisory vote approving the Company’s executive compensation program as disclosed in the proxy. Management seeks affirmation of its pay-for-performance approach, which in 2025 emphasized performance-based incentives tied to bookings, Adjusted EBITDA, and multi-year PSU performance tied to relative TSR and free cash flow conditions. The Board recommends a FOR vote, citing strong 2025 financial results, extensive performance-based compensation design, stockholder engagement following a 2023 say-on-pay failure, and governance safeguards like clawback policies and independent committee oversight.

Director elections

Nominees on the ballot7

Maj. Gen. (Ret.) John W. Maluda
Not independent
Tenure on this board
New nominee
Ownership

Top institutional holders10

Latest 13F quarter
1BARCLAYS PLC12.6%9,416,413$39M
2PINNACLE ASSOCIATES LTD3.1%2,291,029$10M
3VANGUARD CAPITAL MANAGEMENT LLC3.0%2,277,519$10M
4MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3.0%2,248,442$9M
5MASTERS CAPITAL MANAGEMENT LLC2.7%2,000,000$8M
6BlackRock, Inc.2.7%1,997,532$8M
7WEBER CAPITAL MANAGEMENT LLC /ADV2.4%1,766,520$7M
8D. E. Shaw Co., Inc.Activist2.2%1,650,265$7M
9BlackRock, Inc.1.9%1,445,906$6M
10ACADIAN ASSET MANAGEMENT LLC1.9%1,418,616$6M
Filings

Recent key filings

Periodic reports
Definitive proxies
Reference

Frequently asked questions

When is the Telos Corp 2026 annual meeting?
Telos Corp (TLS) holds its 2026 annual shareholder meeting on Thursday, May 7, 2026.
What is the record date for the Telos Corp 2026 meeting?
The record date for the Telos Corp 2026 meeting is Tuesday, March 10, 2026. Shareholders of record on or before that date are eligible to vote.
Who are the director nominees for Telos Corp's 2026 meeting?
The board is presenting 7 director nominees at the Telos Corp 2026 meeting, listed with their independence status and background.
What proposals will shareholders vote on at the Telos Corp 2026 meeting?
Shareholders will vote on 4 proposals at the Telos Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer